Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Rapid Communications in Mass Spectrometry

• Publication date

  2003-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/RCM.1112PMID 12872277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a sensitive assay for the determination of mevalonic acid in urine and its application to clinical studies with rosuvastatin

  2002cited by this paper
• Characterization and comparison of the chromatographic performance of conventional, polar-embedded, and polar-endcapped reversed-phase liquid chromatography stationary phases.

  2002cited by this paper
• Implications of matrix effects in ultra-fast gradient or fast isocratic liquid chromatography with mass spectrometry in drug discovery.

  2002cited by this paper
• Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry.

  2002cited by this paper
• Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries.

  2002cited by this paper
• Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry.

  2001cited by this paper
• Analysis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors using liquid chromatography-electrospray mass spectrometry.

  2001cited by this paper
• Effect of liquid chromatography separation of complex matrices on liquid chromatography-tandem mass spectrometry signal suppression.

  2001cited by this paper
• Urinary excretion and serum concentration of mevalonic acid during acute intake of alcohol.

  2000cited by this paper
• The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds.

  1999cited by this paper
• Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations.

  1998cited by this paper
• Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection.

  1998cited by this paper
• High performance liquid chromatography mobile phase composition optimization for the quantitative determination of a carboxylic acid compound in human plasma by negative ion electrospray high performance liquid chromatography tandem mass spectrometry.

  1998cited by this paper
• A sensitive and selective method for the determination of mevalonic acid in dog plasma by gas chromatography/negative ion chemical ionization-mass spectrometry.

  1997cited by this paper
• Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.

  1996cited by this paper
• Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression

  1996cited by this paper
• Measurement of mevalonic acid in human urine by bench top gas chromatography-mass spectrometry.

  1995cited by this paper
• Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.

  1994cited by this paper
• Determination of urinary mevalonic acid using isotope dilution technique.

  1994cited by this paper
• An improved chemical ionization assay for mevalonic acid.

  1990cited by this paper

• Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma

  2025cites this paper
• Addressing the Uncertainties in the Environmental Analysis, Modeling, Source and Risk Assessment of Emerging Contaminants

  2025cites this paper
• Development of an analytical method for the determination of more than 300 pesticides and metabolites in the particulate and gaseous phase of ambient air

  2024cites this paper
• Evaluation of Proteolytic Digestion Efficiency in Hydrogen Exchange-Mass Spectrometry Experiments Using the Digestible Peptide Score.

  2024cites this paper
• A green LC-MS/MS for energetically assessing an imperative muscle relaxant combination: A clinical pharmacokinetic study in human plasma

  2024cites this paper
• Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations.

  2024cites this paper
• Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy

  2024cites this paper
• Cohort-based strategies as an in-house tool to evaluate and improve phenotyping robustness of LC–MS/MS lipidomics platforms

  2024cites this paper
• An online internal standard technique for high-performance liquid chromatography-inductively coupled plasma mass spectrometry (HPLC-ICP-MS).

  2023cites this paper
• Applications of vacuum MAI on a portable mass spectrometer

  2022cites this paper
• Development and validation of an LC-MS/MS for simultaneous quantification of medium and long chain saturated fatty acids in hamster plasma samples.

  2022cites this paper
• Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry

  2022cites this paper
• Biomarker Assay Validation by Mass Spectrometry

  2022cites this paper
• Therapeutic targeting of the mevalonate–geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer

  2022cites this paper
• Binding the gap between experiments, statistics, and method comparison: A tutorial for computing limits of detection and quantification in univariate calibration for complex samples.

  2021cites this paper
• Matrix Normalization Techniques for Definitive Urine Drug Testing.

  2021cites this paper
• Abeta CSF LC-MS

  2021cites this paper
• The effects of special patient population plasma on pharmacokinetic quantifications using LC-MS/MS.

  2020cites this paper
• Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC-MS bioanalysis.

  2020cites this paper
• A preliminary study procedure for detection of polyamines in plasma samples as a potential diagnostic tool in prostate cancer.

  2020cites this paper
• Determination of Tryptophan and Kynurenine by LC-MS/MS by Using Amlodipine as an Internal Standard.

  2020cites this paper
• Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers.

  2020cites this paper
• Differential adsorption of analyte and deuterated analogue onto the rotor seal of the injector in high-performance liquid chromatography/electrospray ionisation mass spectrometry.

  2019cites this paper
• STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.

  2019cites this paper
• A Tool for Automatic Correction of Endogenous Concentrations: Application to BHB Analysis by LC-MS-MS and GC-MS.

  2019cites this paper
• We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists Implementing Multimodal Biometric Solutions in Embedded Systems Biometrics - Unique and Diverse Applications in Nature, Science, and Technology

  2019cites this paper
• Development, validation and application of a new method to correct the nonlinearity problem in LC-MS/MS quantification using stable isotope labeled internal standards.

  2019cites this paper
• Two-dimensional qNMR of anthraquinones in Frangula alnus (Rhamnus frangula) using surrogate standards and delay time adaption.

  2019cites this paper
• Analytical Methods for the Determination of Rosuvastatin in Pharmaceutical Formulations and Biological Fluids: A Critical Review

  2018cites this paper
• Considerations regarding the validation of chromatographic mass spectrometric methods for the quantification of endogenous substances in forensics.

  2018cites this paper
• Targeting human urinary metabolome by LC-MS/MS: a review.

  2018cites this paper
• Quantification of free fatty acids in human stratum corneum using tandem mass spectrometry and surrogate analyte approach.

  2018cites this paper
• Special Considerations for Liquid Chromatography-Tandem Mass Spectrometry Method Development.

  2018cites this paper
• Determination of dehydroepiandrosterone and its biologically active oxygenated metabolites in human plasma evinces a hormonal imbalance during HIV-TB coinfection

  2018cites this paper
• Simultaneous determination of 14 oral antihyperglycaemic drugs in human urine by liquid chromatography–tandem mass spectrometry

  2018cites this paper
• Volumetric absorptive MicroSampling vs. other blood sampling materials in LC–MS‐based protein analysis – preliminary investigations

  2018cites this paper
• Quantification of eicosanoids and their metabolites in biological matrices: a review.

  2018cites this paper
• Using ambient mass spectrometry and LC–MS/MS for the rapid detection and identification of multiple illicit street drugs

  2018cites this paper
• Heavy water enhancement of fluorescence signal in reversed-phase liquid chromatography.

  2018cites this paper
• A review of the pharmaceutical exposome in aquatic fauna

  2018cites this paper
• Standard addition with internal standardisation as an alternative to using stable isotope labelled internal standards to correct for matrix effects-Comparison and validation using liquid chromatography-​tandem mass spectrometric assay of vitamin D.

  2018cites this paper
• Development of an assay for vitamin D in biological samples

  2018cites this paper
• Accurate quantification of PGE2 in the polyposis in rat colon (Pirc) model by surrogate analyte‐based UPLC–MS/MS

  2018cites this paper
• Development of Mevalonic Acid Biosensor Using Amperometric Technique Based on Nanocomposite of Nicotinamide Adenine Dinucleotide and Carbon Nanotubes

  2017cites this paper
• Development of a validated LC- MS/MS method for the quantification of 19 endogenous asthma/COPD potential urinary biomarkers.

  2017cites this paper
• Comparison Between LC–MS and Ligand‐Binding Assay Approaches for Biomarker Quantification

  2017cites this paper
• Polyoxometalate incorporated polymer monolith microextraction for highly selective extraction of antidepressants in undiluted urine.

  2017cites this paper
• Overcome the Endogenous Levels in Biomarker Quantitation Using LC–MS

  2017cites this paper
• Evaluation and application of a targeted SPE-LC-MS method for quantifying plant hormones and phenolics in Arabidopsis.

  2017cites this paper
• Sample preparation techniques for mass spectrometry in the clinical laboratory

  2017cites this paper
• Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure.

  2017cites this paper
• Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor.

  2017cites this paper
• Sample Preparation Methods for Targeted Biomarker Quantification by LC‐MS

  2017cites this paper
• Enhancement and Suppression of Ionization in Drug Analysis Using HPLC-MS/MS in Support of Therapeutic Drug Monitoring: A Review of Current Knowledge of Its Minimization and Assessment: Erratum.

  2017cites this paper
• Rapid identification of seized controlled substances and related compounds by tandem mass spectrometry without chromatography.

  2016cites this paper
• Surrogate analyte approach for quantitation of endogenous NAD(+) in human acidified blood samples using liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

  2016cites this paper
• A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.

  2016cites this paper
• Quantitative analysis of endogenous compounds.

  2016cites this paper
• Isotope Inversion Experiment evaluating the suitability of calibration in surrogate matrix for quantification via LC-MS/MS-Exemplary application for a steroid multi-method.

  2016cites this paper
• Making methods rugged for regulated bioanalysis.

  2015cites this paper
• Drug confirmation by mass spectrometry: Identification criteria and complicating factors.

  2015cites this paper
• An Economical Online Solid-Phase Extraction LC-MS/MS Method for Quantifying Methylprednisolone.

  2015cites this paper
• Mass spectrometric quantification of amyloid-beta in cerebrospinal fluid and plasma

  2015cites this paper
• Optimization, validation and application of an assay for the activity of HMG-CoA reductase in vitro by LC–MS/MS

  2015cites this paper
• Matrix Effects in Liquid Chromatography–Electrospray Ionization–Mass Spectrometry

  2015cites this paper
• Bioanalytical insights into mediator lipidomics.

  2015cites this paper
• Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.

  2015cites this paper
• Assesment of endocrinal and biochemical entities through liquid chromatography–tandem mass spectrometry/mass spectrometer: Inter-relative investigation of the interaction based cardiovascular formulation

  2015cites this paper
• QUANTIFICATION OF BIOANALYTES THROUGH LCMS/MS: CLINICAL INVESTIGATION ON EFFICACY OF A COMBINED FORMULATED CARDIOVASCULAR MARKETED DRUG

  2014cites this paper
• Application of Screening Experimental Designs to Assess Chromatographic Isotope Effect upon Isotope-Coded Derivatization for Quantitative Liquid Chromatography–Mass Spectrometry

  2014cites this paper
• QUANTIFICATION OF AMINO ACIDS IN RAT URINE BY SOLID-PHASE EXTRACTION AND LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY: APPLICATION TO RADIATION INJURY RAT MODEL

  2014cites this paper
• Quantification of urinary mevalonic acid as a biomarker of HMG-CoA reductase activity by a novel translational LC-MS/MS method.

  2014cites this paper
• Do deuterium labeled internal standards correct for matrix effects in LC-MS/MS assays? A case study using plasma free metanephrine and normetanephrine.

  2014cites this paper
• STUDIES OF PROTEIN FUNCTION BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY

  2014cites this paper
• A clinical biomarker assay for the quantification of d3-creatinine and creatinine using LC-MS/MS.

  2014cites this paper
• Determination of Celecoxib in human plasma using liquid chromatography with high resolution time of flight-mass spectrometry.

  2014cites this paper
• Quantification of free and total desmosine and isodesmosine in human urine by liquid chromatography tandem mass spectrometry: a comparison of the surrogate-analyte and the surrogate-matrix approach for quantitation.

  2014cites this paper
• Impact of calibrator concentrations and their distribution on accuracy of quadratic regression for liquid chromatography-mass spectrometry bioanalysis.

  2014cites this paper
• Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS.

  2014cites this paper
• Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

  2014cites this paper
• Simultaneous determination of seven β2-agonists in human and bovine urine by isotope dilution liquid chromatography-tandem mass spectrometry using compound-specific minimally 13C-labelled analogues.

  2014cites this paper
• Mechanismen und Minimierung von Matrixeffekten in der quantitativen Spurenanalytik mit der Elektrospray-Massenspektrometrie

  2014cites this paper
• Reverse-Polynomial Dilution Calibration Methodology Extends Lower Limit of Quantification and Reduces Relative Residual Error in Targeted Peptide Measurements in Blood Plasma*

  2014cites this paper
• Matrix effect and methods for its elimination in bioanalytical methods using chromatography-mass spectrometry

  2014cites this paper
• Validation of liquid chromatography-tandem mass spectrometry for mevalonate in human plasma: Incompetent effects between treated atorvastatin & its combination with olmesartan in cardiovascular patients

  2014cites this paper
• An LC-MS/MS method for the simultaneous determination of goserelin and testosterone in rat plasma for pharmacokinetic and pharmacodynamic studies.

  2014cites this paper
• Simultaneous determination of propofol and drugs used in general anesthesia by developed and validated liquid chromatographic methods : a preclinical study for drug-drug interaction analysis

  2014cites this paper
• Mass Spectrometry–Based Candidate Reference Measurement Procedure for Quantification of Amyloid- (cid:2) in Cerebrospinal Fluid

  2014cites this paper
• Capillary electrophoresis-mass spectrometry for direct determination of urinary modified nucleosides. Evaluation of synthetic urine as a surrogate matrix for quantitative analysis.

  2013cites this paper
• Determination of the stress biomarker corticosterone in serum of tumor-bearing mice by surrogate-based liquid chromatography-tandem mass spectrometry.

  2013cites this paper
• Case studies: the impact of nonanalyte components on LC-MS/MS-based bioanalysis: strategies for identifying and overcoming matrix effects.

  2013cites this paper
• Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins.

  2013cites this paper
• LC‐MS Bioanalysis of Endogenous Compounds as Biomarkers

  2013cites this paper
• Comparison of different methods aiming to account for/overcome matrix effects in LC/ESI/MS on the example of pesticide analyses

  2013cites this paper
• Quantification of aconitine in post-mortem specimens by validated liquid chromatography-tandem mass spectrometry method: three case reports on fatal 'monkshood' poisoning.

  2013cites this paper
• A surrogate analyte method to determine D-serine in mouse brain using liquid chromatography-tandem mass spectrometry.

  2013cites this paper
• A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients.

  2013cites this paper
• Best Practices in Biological Sample Preparation for LC‐MS Bioanalysis

  2013cites this paper
• Use of Internal Standards in LC‐MS Bioanalysis

  2013cites this paper
• Quantification of Endogenous Analytes in Biofluids by a Combination of LC‐MS and Construction of Calibration Curves Using Stable‐Isotopes as Surrogate Analytes with True Biological Control Matrices

  2013cites this paper